Biblio

Export 366 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2016
L. T. Grinberg, Anghinah, R., Nascimento, C. Fernandes, Amaro, E., Leite, R. P., Martin, Mda Graça, Naslavsky, M. S., Takada, L. T., Filho, W. Jacob, Pasqualucci, C. A., and Nitrini, R., “Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.”, J Alzheimers Dis, vol. 54, no. 1, pp. 169-74, 2016.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., “Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., “Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., “Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., “Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
T. Särkämö, Laitinen, S., Numminen, A., Kurki, M., Johnson, J. K., and Rantanen, P., “Clinical and Demographic Factors Associated with the Cognitive and Emotional Efficacy of Regular Musical Activities in Dementia.”, J Alzheimers Dis, vol. 49, no. 3, pp. 767-81, 2016.
E. Christiane Gertje, Pluta, J., Das, S., Mancuso, L., Kliot, D., Yushkevich, P., and Wolk, D., “Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1027-1037, 2016.
H. Woong Roh, Hong, C. Hyung, Lee, Y., Lee, K. Soo, Chang, K. Jung, Kang, D. Ryong, Lee, J. - D., Choi, S. Hye, Kim, S. Yoon, Na, D. L., Seo, S. Won, Kim, D. Kwan, Back, J. Hwan, Chung, Y. Ki, Lim, K. Young, Noh, J. Sung, and Son, S. Joon, “Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).”, J Alzheimers Dis, vol. 53, no. 2, pp. 463-73, 2016.
Y. - L. Chang, Yen, Y. - S., Chen, T. - F., Yan, S. - H., and Tseng, W. - Y. Isaac, “Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., “Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.”, J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., “Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., “Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.”, J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., “The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, “Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
O. C. Küster, Kösel, J., Spohn, S., Schurig, N., Tumani, H., von Arnim, C. A. F., and Uttner, I., “Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.”, J Alzheimers Dis, vol. 52, no. 2, pp. 519-28, 2016.
J. Middelstädt, Folkerts, A. - K., Blawath, S., and Kalbe, E., “Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression.”, J Alzheimers Dis, vol. 54, no. 1, pp. 253-68, 2016.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., “Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden.”, J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
B. Brüggenjürgen, Andersohn, F., Burkowitz, J., Ezzat, N., Gaudig, M., and Willich, S. N., “Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1365-1372, 2016.
K. Hensley and Kursula, P., “Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.”, J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
K. Ritter, Lange, C., Weygandt, M., Mäurer, A., Roberts, A., Estrella, M., Suppa, P., Spies, L., Prasad, V., Steffen, I., Apostolova, I., Bittner, D., Gövercin, M., Brenner, W., Mende, C., Peters, O., Seybold, J., Fiebach, J. B., Steinhagen-Thiessen, E., Hampel, H., Haynes, J. - D., and Buchert, R., “Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1319-1331, 2016.
S. Mazzeo, Santangelo, R., Bernasconi, M. Paola, Cecchetti, G., Fiorino, A., Pinto, P., Passerini, G., Falautano, M., Comi, G., and Magnani, G., “Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1495-1508, 2016.
J. René Thyrian, Eichler, T., Michalowsky, B., Wucherer, D., Reimann, M., Hertel, J., Richter, S., Dreier, A., and Hoffmann, W., “Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive, Multivariate Descriptive Analysis Using Data from the DelpHi-Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 609-17, 2016.

Pages